home / stock / lgvn / lgvn news


LGVN News and Press, Longeveron Inc. From 03/11/22

Stock Information

Company Name: Longeveron Inc.
Stock Symbol: LGVN
Market: NASDAQ
Website: longeveron.com

Menu

LGVN LGVN Quote LGVN Short LGVN News LGVN Articles LGVN Message Board
Get LGVN Alerts

News, Short Squeeze, Breakout and More Instantly...

LGVN - Longeveron slips after Q4 earnings amid likely delay in key data readout

The clinical-stage biotechnology company Longeveron (NASDAQ:LGVN) has lost ~10% in the pre-market Friday after the company signaled a potential delay for results from its Aging Frailty trial for the lead candidate, Lomecel-B. The data from the Phase 1/2 trial called “HERA...

LGVN - Rivian Automotive, DocuSign, DiDi Global among premarket losers' pack

Orphazyme (NASDAQ:ORPH) -39% on commencement of in-court restructuring. Tilly's (NYSE:TLYS) -25% on Q4 earnings release. AgriFORCE Growing Systems (NASDAQ:AGRI) -18%. DocuSign (NASDAQ:DOCU) -16% on Q4 earnings release. Sunworks (NASDAQ:SUNW) -15% o...

LGVN - Longeveron GAAP EPS of -$0.20 beats by $0.05, revenue of $0.21M

Longeveron press release (NASDAQ:LGVN): Q4 GAAP EPS of -$0.20 beats by $0.05. Revenue of $0.21M (-82.2% Y/Y). CEO comment: “Since our IPO in February of last year, important progress has been made in advancing Lomecel-B into next phase trials, including initiation of Phase 2 trials in ...

LGVN - Longeveron Announces Fourth Quarter and Full Year 2021 Financial Results and Operational Progress

Currently Enrolling Clinical Trials with Lomecel-B in Three Disease Indications: Hypoplastic Left Heart Syndrome (Phase 2a), Alzheimer’s Disease (Phase 2a), and Covid-related Acute Respiratory Distress Syndrome (Phase 1) Lomecel-B for HLHS Granted Rare Pediatric Disease a...

LGVN - Amazon Stock Split 2022: Is the AMZN Split Good or Bad? 4 Analysts Weigh In.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Amazon (NASDAQ: AMZN ) stock is on the move Thursday after the e-commerce giant announced a stock split taking place this year alongside a $10 billion share buyback. Source: Frederic Legrand – COMEO / Shutt...

LGVN - Why Is Longeveron (LGVN) Stock Up Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors will remember Longeveron (NASDAQ: LGVN ) as a late 2021 meme stock. The biopharmaceutical company briefly shot to market prominence in late November 2021 before beginning a gradual decline. LGVN stock has sp...

LGVN - Kala, Natera top healthcare gainers; Sunshine Biopharma, Myomo lead losers' pack

Gainers: Kala Pharmaceuticals (NASDAQ:KALA) +20%. Natera (NASDAQ:NTRA) +17%. Chemomab Therapeutics (NASDAQ:CMMB) +13%. Selecta Biosciences (NASDAQ:SELB) +11%. Longeveron (NASDAQ:LGVN) +7%. Losers: Sunshine Biopharma (NASDAQ:SBFM) -32%. My...

LGVN - CEI, EBIX and KALA among pre market gainers

Enservco (NYSE:ENSV) +32%. Indonesia Energy (NYSE:INDO) +30% mobilizes drilling rig to commence drilling of two back-to-back production wells at Kruh block. Houston American Energy (NYSE:HUSA) +15%. TMC the metals company (NASDAQ:TMC) +15%. Longeveron (NASDAQ:LGVN) +15% ahead o...

LGVN - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, trader! We’re preparing for another busy day of trading with the biggest pre-market stock movers for Thursday! Source: oneinchpunch/Shutterstock.com Penny stocks continue to see heavy volatility...

LGVN - Longeveron spikes ahead of Q4 2021 earnings

The shares of Longeveron (LGVN +35.0%) a clinical-stage biotechnology company focused on cellular therapies have risen sharply on Wednesday ahead of its Q4 2021 results scheduled for tomorrow before the market open. Currently, approximately 1.7 million Longeveron (NASDAQ:LGVN) shares have cha...

Previous 10 Next 10